Mia's Feed
Medical News & Research

Increased Risk of Parkinson's Disease Linked to Metabolic Syndrome, Study Shows

Increased Risk of Parkinson's Disease Linked to Metabolic Syndrome, Study Shows

Share this article

A new study links metabolic syndrome to an increased risk of Parkinson's disease. Maintaining metabolic health may help reduce the likelihood of developing neurodegenerative conditions. Source: Medical Xpress.

1 min read

Recent research published in the journal Neurology has highlighted a noteworthy association between metabolic syndrome and an elevated risk of developing Parkinson's disease. The study, conducted by scientists from the Karolinska Institutet in Stockholm, examined data from over 467,200 individuals with an average age of 57, followed for a median period of 15 years. Findings revealed that individuals with metabolic syndrome—characterized by risk factors such as excess abdominal fat, high blood pressure, elevated blood sugar, high triglycerides, and low HDL (

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Strategies to Alleviate Primary Care Physician Burnout

Innovative approaches such as protected message handling time slots, team-based workflows, and recognizing gender differences are helping combat primary care doctor burnout caused by digital message overload. Discover how these strategies improve physician well-being and patient care.

New Insights into How the Brain Uses Objects to Navigate and Find Direction

Recent research reveals how the brain's postsubiculum encodes objects to aid in navigation and spatial orientation, offering insights into neurodegenerative conditions like Alzheimer's.

New Research Reveals a Biological Connection Between FND and Chronic Pain That Could Reduce NHS Healthcare Costs

A groundbreaking systematic review uncovers a shared neurobiological link between Functional Neurological Disorder and chronic pain, offering new pathways for treatment and NHS cost savings.